Immunization, measles second dose (% of children by the nationally) in France
France: Immunization, measles second dose (% of children by the nationally) was 93.0% in 2024. ▲ Rising
Immunization, measles second dose in France, 2010–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
In 2024, immunization, measles second dose in France stood at 93.0%. That is the highest value across all 15 years on record.
Compared with earlier readings it is up 20.8% over ten years.
Over the whole period, immunization, measles second dose in France peaked at 93.0% in 2022 and was at its lowest, 61.0%, in 2010.
France ranks 45th of 178 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 15 years of available data.
Immunization, measles second dose (% of children by the nationally) in France, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2010 | 61.0% | — |
| 2011 | 67.0% | +9.8% |
| 2012 | 72.0% | +7.5% |
| 2013 | 75.0% | +4.2% |
| 2014 | 77.0% | +2.7% |
| 2015 | 79.0% | +2.6% |
| 2016 | 80.0% | +1.3% |
| 2017 | 80.0% | +0.0% |
| 2018 | 83.0% | +3.8% |
| 2019 | 86.0% | +3.6% |
| 2020 | 91.0% | +5.8% |
| 2021 | 91.0% | +0.0% |
| 2022 | 93.0% | +2.2% |
| 2023 | 93.0% | +0.0% |
| 2024 | 93.0% | +0.0% |
France compared with similar countries
- France's 93.0% is above the median for high income countries, which is 92.0%, 1.0× the median. (63 countries reporting)
- France's 93.0% is above the median for Europe & Central Asia, which is 92.0%, 1.0× the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 76.0% | 61.0% | 86.0% | 10 |
| 2020s | 92.2% | 91.0% | 93.0% | 5 |
Countries ranked near France
More health data for France
- Un projection of annual infant deaths, annual growth rate -1.31 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0689 % change on previous year (2090)
- Un projection of annual infant deaths 603 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -0.7875 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0244 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8291 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0255 units per person (2025)
Frequently asked questions
- What is immunization, measles second dose in France?
- Immunization, measles second dose in France was 93.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in France?
- The highest recorded value was 93.0% in 2022.
- What is the lowest immunization, measles second dose recorded in France?
- The lowest recorded value was 61.0% in 2010.
- How does France rank for immunization, measles second dose?
- France ranks 45th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in France?
- Over the last ten years it is up 20.8%. The long-run trend across the full record is rising.
- Where does this France data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.